The Muscle Loss Problem on GLP-1s: Why Body Composition Matters More Than the Scale

There’s a conversation happening in clinical medicine right now about GLP-1 medications that most patients haven’t been part of. It goes something like this: yes, these medications produce significant weight loss. But a meaningful portion of what patients are losing isn’t fat. It’s muscle. And in some cases, that muscle loss is severe enough to raise concerns about long-term outcomes that far outweigh the benefits of the weight lost.

If you’re on a GLP-1, or thinking about starting one, this is a conversation you need to be part of. Because the difference between “GLP-1s work great” and “GLP-1s work great when properly managed” is enormous — and the failure to manage them properly is showing up in emergency rooms as fractures, in nursing homes as sarcopenic elderly patients, and in the mirror as people who lost weight but don’t look healthy.

The good news is this is completely preventable. But prevention requires knowing about the problem, tracking the right things, and doing the specific work that keeps the muscle you have. Let’s walk through what’s happening, why it matters, and what to do about it.

What GLP-1s actually do to body composition

GLP-1 medications work primarily by reducing appetite. You feel full faster, you feel less interest in food, and you eat significantly less overall. This is why they produce weight loss.

The problem is what happens when you’re eating significantly less: your body has to get energy from somewhere, and it takes it from both fat stores and muscle tissue. Without specific intervention, the body doesn’t preferentially spare muscle. It burns whatever’s available.

Studies of body composition changes on GLP-1s have found that up to 40 percent of the weight lost can be lean mass. Some studies find lower numbers, some find higher, but the pattern is consistent: without active muscle preservation, patients lose meaningful lean tissue along with fat.

Think about what that means practically. A patient loses 50 pounds on a GLP-1. Twenty of those pounds are lean tissue — muscle, bone, connective tissue. They now have significantly less muscle than they started with, and they’ve lost the metabolic advantage that muscle provides.

Why muscle loss matters so much

Losing muscle isn’t just a cosmetic issue. Muscle serves several critical functions that most patients don’t think about until they lose it.

Muscle is your metabolic engine. Skeletal muscle burns calories at rest — significantly more than fat tissue does. When you lose muscle, your baseline metabolic rate drops. This is why patients who lose weight on GLP-1s often gain the weight back faster than they lost it once they stop the medication: their metabolism is now lower than it was before, so their old eating patterns produce more weight gain.

Muscle is your insulin sink. Muscle tissue is where your body uses insulin most efficiently. When you have adequate muscle mass, insulin sensitivity is preserved and metabolic health is protected. When muscle is depleted, insulin resistance often worsens over time — the opposite of what you probably wanted from your weight loss.

Muscle protects your bones. Bone strength is significantly influenced by the mechanical load that muscle places on the skeleton. When muscle declines, bone follows. This is why some GLP-1 users are experiencing accelerated bone density loss, and it’s why we’re already seeing concern in orthopedic and geriatric medicine about the long-term skeletal consequences of GLP-1 therapy in older adults.

Muscle predicts functional independence in aging. The single best predictor of whether someone will be independently mobile in their 70s and 80s is their muscle mass in their 40s, 50s, and 60s. Losing muscle now is a direct trade for reduced function later. This isn’t hypothetical — it’s one of the most robust findings in aging research.

Muscle produces myokines that affect brain and immune function. Muscle isn’t just tissue that moves your bones. Contracting muscle releases signaling molecules called myokines that affect brain health, immune function, mood, and metabolism throughout the body. Less muscle means less myokine production and less of these benefits.

Muscle appearance affects how you feel about your body. Weight loss that comes primarily from muscle depletion produces the “skinny fat” or “ozempic face” appearance that many patients report being disturbed by. The scale went down but the body doesn’t look healthier. That’s what muscle loss looks like.

Why the scale is the wrong tool

The scale can’t tell you what you lost. That’s the fundamental problem.

Two patients can lose the same 30 pounds and have completely different outcomes:

Patient A loses 30 pounds. Of that: 24 pounds of fat, 6 pounds of lean mass. Body fat percentage dropped from 34% to 26%. Waist measurement dropped six inches. Clothing fits better, they look and feel stronger, energy is good, labs improved.

Patient B loses 30 pounds. Of that: 15 pounds of fat, 15 pounds of lean mass. Body fat percentage dropped only slightly, from 34% to 30%. Face looks gaunt, arms look thin but not defined, energy is low, they’re worried about how they look.

The scale showed the same weight loss. The reality is completely different. And you can’t tell which patient you’re becoming without measuring body composition.

This is why body composition measurement is central to how we run GLP-1 programs at The Tide. If you don’t know what you’re losing, you can’t tell whether treatment is working the way you want it to.

How to actually measure body composition

There are several ways to measure body composition, ranging from research-grade to practical:

DEXA scan (dual-energy X-ray absorptiometry) is the clinical gold standard. It uses low-dose X-rays to differentiate fat, lean mass, and bone mineral density. Accuracy is excellent. Cost is moderate ($100-200 per scan) and availability is widespread. This is what serious body composition tracking uses.

Hydrostatic weighing and air displacement (Bod Pod) are also highly accurate but less widely available and more time-consuming.

Bioimpedance analysis (BIA) — including InBody, Tanita, and clinical BIA scales — is more accessible and gives useful trend data. Absolute accuracy is not as good as DEXA but the ability to track change over time is very useful. Many gyms and clinics have BIA scales available.

Circumference measurements — waist, hips, thighs, arms — provide useful trend data even without a device. Not a substitute for actual body composition analysis but better than nothing.

At The Tide, we use body composition assessment at baseline for all GLP-1 patients and at regular intervals during treatment. The measurement itself is quick, but what we do with the data is what matters.

What preserving muscle on a GLP-1 actually requires

Losing weight without losing muscle takes specific work. Here’s what actually preserves muscle during a GLP-1 program.

Protein intake at levels most patients aren’t achieving

The single most important factor in muscle preservation during weight loss is protein intake. And the amount required is higher than most patients realize.

Standard recommendations of 0.8 g/kg of body weight per day (about 55g for a 150-lb person) are inadequate for muscle preservation during weight loss. Research on protein intake during weight loss consistently shows that 1.2 to 1.6 g/kg (about 80-110g for that same person) is required to preserve lean mass. For patients on GLP-1s specifically, some clinicians recommend even higher — up to 2.0 g/kg.

The problem is that GLP-1s suppress appetite dramatically, and protein tends to be the macronutrient patients cut first because it feels heavy. Patients often end up eating 40-50 grams of protein a day when they need 90-120. This is the primary driver of muscle loss.

Meeting protein targets on a GLP-1 requires intention. It means starting the day with protein rather than saving appetite for later. It often means protein shakes or supplements to make up the gap. It means treating protein as non-negotiable even when nothing sounds good.

Resistance training, not just walking

Cardio is useful but doesn’t preserve muscle. The signal your body needs to keep muscle is mechanical loading — lifting heavy things, working against resistance, doing muscle-building work.

Two to three resistance training sessions per week is the minimum for muscle preservation. This doesn’t have to be complex. Basic compound movements — squats, lunges, rows, presses — done regularly are sufficient. But they need to be done consistently, and they need to be progressive (getting slightly harder over time).

Many GLP-1 patients report low energy for exercise because they’re eating so little. This is another reason protein intake matters — protein and adequate calories from healthy sources are what makes recovery from training possible.

Not losing weight too fast

Rapid weight loss is muscle-destructive weight loss. The faster you lose weight, the higher the proportion that comes from lean mass. Sustainable rates of weight loss — typically 0.5-1% of body weight per week — preserve more muscle than aggressive rates.

This is a place where GLP-1 dosing decisions matter. Higher doses produce faster weight loss, which sounds like a good thing, but often at the cost of more muscle loss. Working at moderate doses over longer periods often produces better body composition outcomes than aggressive protocols.

Adequate micronutrients

Muscle maintenance requires specific nutrients that GLP-1 patients often become depleted in. Vitamin D, magnesium, and B12 all play roles in muscle function and protein synthesis. Iron deficiency limits exercise capacity and recovery. Any of these being low compromises muscle preservation. We wrote about the iron issue specifically in our article on low iron in women — it’s particularly relevant for female GLP-1 patients.

Sleep

Muscle recovery happens primarily during sleep. Growth hormone release, protein synthesis, and tissue repair all peak during deep sleep. Patients who are sleep-deprived don’t build or maintain muscle the way well-rested patients do, regardless of how well they eat or train.

Supporting peptides and other protocols

Beyond nutrition and training, several peptide protocols can support muscle preservation during GLP-1 therapy. This is one of the reasons peptide therapy and metabolic therapy overlap so heavily.

Growth hormone-releasing peptides like CJC-1295 with Ipamorelin and sermorelin support endogenous growth hormone release, which in turn supports muscle preservation, recovery, and body composition. These aren’t magic — they don’t replace protein and training — but they can meaningfully support the muscle preservation effort.

BPC-157 and TB-500 can support recovery from training, which matters more when patients are eating less than usual and recovering from workouts more slowly.

For patients on GLP-1s who are experiencing significant muscle loss, or who want to be proactive about preventing it, we often incorporate supporting peptides into the protocol. This is a discussion we have with every serious GLP-1 patient at The Tide.

What we do at The Tide

Body composition management is built into our GLP-1 program from day one, not added later when problems appear.

Baseline measurement. Before starting a GLP-1, we measure body composition — fat mass, lean mass, visceral fat. This gives us a starting point that matters more than starting weight.

Nutrition planning with protein targets. Every GLP-1 patient gets specific protein targets in grams per day, along with practical strategies for hitting them despite reduced appetite. This is not “eat more protein” advice. It’s a specific number and a specific plan.

Resistance training guidance. For patients who don’t already train, we build a resistance training recommendation into their plan. This may mean working with a personal trainer, joining a gym with structured programs, or starting with home-based resistance work.

Ongoing body composition tracking. We reassess body composition at intervals during treatment. If lean mass is dropping, we intervene — adjusting nutrition, dosing, or supporting protocols — before the loss becomes severe.

Supporting peptides when appropriate. For patients where muscle preservation is a particular concern, or where body composition is trending in the wrong direction, we discuss adding supporting protocols like CJC-1295 with Ipamorelin or other approaches.

Long-term thinking. We plan for the maintenance phase from day one. What does staying on a lower dose look like? What does transitioning off look like? How do we protect the body composition you’ve built during treatment?

This is what serious GLP-1 care looks like. It’s not what most patients get, but it’s what most patients need.

For patients already on a GLP-1

If you’re already on a GLP-1 and this article is the first time you’re thinking about muscle loss, you’re not alone — and it’s not too late to change course.

Start with these steps:

Measure where you actually are. Get a DEXA scan or high-quality body composition assessment. Know what your fat mass, lean mass, and visceral fat currently look like. This gives you a starting point for the next phase.

Increase protein intake. Aim for 1.2-1.6 grams per kg of body weight per day. For most patients, this means 90-120g/day. Track it for a week to see where you actually are — most patients are surprised how low they’re eating.

Start resistance training if you’re not already. Two to three sessions per week, focused on compound movements. Even short sessions matter more than none.

Consider whether your current dose is right. If you’ve lost weight quickly and are still losing, discuss with your provider whether a dose reduction might be appropriate. Slower weight loss preserves more muscle.

Get labs. Check ferritin, B12, vitamin D, and thyroid at minimum. Nutrient deficiencies limit muscle preservation.

Consider whether you need more comprehensive care. If your current provider isn’t measuring body composition, isn’t giving you specific protein guidance, and isn’t discussing muscle preservation with you, they’re not managing this dimension of your care. It may be time to move to a program that does.

The larger point

GLP-1 medications are remarkable tools when used well. They can transform patients’ relationships with food, dramatically improve metabolic markers, and produce lasting improvements in health. But “used well” is a meaningful qualifier. Prescribed by an online service that doesn’t measure body composition, doesn’t guide nutrition, doesn’t track lean mass, and doesn’t intervene when muscle is being lost — these medications can cause harm alongside benefit.

The difference between the two experiences comes down to whether someone is actually managing your care.

At The Tide, this is a core part of what we do. Our approach to tirzepatide and semaglutide is built around comprehensive management — including body composition — not just prescription. Our broader metabolic program integrates GLP-1 therapy with the nutrition, monitoring, and supporting protocols that actually produce the outcomes patients want.

If you’d like to talk about how your current GLP-1 experience is going, or how to start one right, schedule a consultation. Body composition matters. The scale isn’t the whole story. Let’s make sure you’re building the body you actually want, not just chasing a number.